About
With recent improvements in acquisition speed and sensitivity of mass spectrometers, coupled with the robustness and throughput provided by microflow chromatography, researchers can now analyze large numbers of biological samples with short run times, accelerating biological research.

In this webinar, Birgit will share her research around Acute Kidney Injury (AKI) and human breast cancer.  She will discuss how her lab at the Buck Institute for Research on Aging, utilized the latest high-resolution mass spectrometry solution from SCIEX, the ZenoTOF 7600 system, and a novel high-sensitivity data independent acquisition workflow, Zeno SWATH DIA, to study both a mouse acute kidney injury model (AKI) and a human breast cancer cohort that consisted of FFPE-preserved specimen of 5 cancer subtypes and healthy controls.

By attending this webinar, you will learn:

  • Comprehensive data independent acquisition, with 80 variable windows, is a fast robust MS workflow for deciphering disease mechanisms and disease pathways

  • Short microflow gradients maintain quantification accuracy and accelerate quantitative protein profiling workflows in mammalian tissues 

  • The kidney proteome is completely remodeled during kidney injury

  • Optimized FFPE tissue analysis (with up to 6,000 proteins quantified) highlights breast cancer biology and cancer progression in 5 different breast cancer subtypes


    • Who should attend this webinar?

    This webinar is aimed at people working as application scientists, postdoctoral fellows/researchers, professor/assistant/associate professor, lab supervisor/manager/director, or a staff scientist in any of these fields: Academic Research, Pharmaceuticals, Life Science Research, Proteomics Centers/Institutes, Cancer Research Centers, AKI Research Centers, Mass spectrometry Labs, Hospitals, CRO/CMOs, Drug Discovery Labs etc.
    Presenter
    1681203391-849136732d86b65e
    Birgit Schilling, PhD
    Professor, Director of the Mass Spectrometry Center | Buck Institute for Research on Aging
    Dr. Birgit Schilling has worked at the Buck Institute for Research on Aging in the San Francisco Bay Area since 2000 as Professor and Director of the Mass Spectrometry Technology Center, specifically focusing on data-independent acquisition technologies and large-scale proteome quantification.

    Dr. Schilling received her Ph.D. in Germany and then moved to the University of California San Francisco (UCSF) as a postdoctoral fellow.

    Dr. Schilling is interested in translational research and research that may aim toward therapeutic interventions to improve human aging or age-related diseases, specifically osteoarthritis, kidney injury and cancer.

    Dr. Schilling uses modern proteomic technologies to investigate mechanisms of aging, senescence and cancer and uses this knowledge to develop biomarkers and targets for interventions.
    Register To Watch Recording
    First Name*
    Last Name*
    Email Address*
    Organisation *
    Job Title*
    State/Province
    Country*
    Business phone
    Zip code
    Yes, I want to receive marketing communications from SCIEX.*
    By submitting your information, you agree that SCIEX may collect and further process your personal data
    in accordance with its Privacy Policy. You may object to receiving further information at any time.
    Yes
    No
    Marketing Permission
    ✓ Yes, I approve the webinar sponsor(s) to send me emails about relevant events, products, services, and promotions that may be of interest to me.*
    Privacy Policy
    ✓ Yes, I consent to AZoNetwork’s Privacy Policy*
    We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.
    Powered by BigMarker